Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manisha Pandey

Showing results (141-150 of 146) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 146 results.
Trials|November 20, 2024
A phase 1 randomized controlled trial of a peptide-based group A streptococcal vaccine in healthy volunteersVanessa Meier-Stephenson, Michael T Hawkes, Catherine Burton, et al.
Clinical & Translational Immunology|March 18, 2021
Antibodies to neutralising epitopes synergistically block the interaction of the receptor-binding domain of SARS-CoV-2 to ACE 2Manisha Pandey, Victoria Ozberk, Sharareh Eskandari, et al.
Lung India : Official Organ of Indian Chest Society|April 30, 2022
Silent Hypoxia in Coronavirus disease-2019: Is it more dangerous? -A retrospective cohort studyPrashant Sirohiya, Arunmozhimaran Elavarasi, Hari Krishna Raju Sagiraju, et al.
Indian Journal of Community Medicine : Official Publication of Indian Association of Preventive & Social Medicine|February 6, 2023
The Effectiveness of SARS-CoV-2 Vaccination in Preventing Severe Illness and Death - Real-world Data from a Cohort of Patients Hospitalized with COVID-19Hari Krishna Raju Sagiraju, Arunmozhimaran Elavarasi, Nishkarsh Gupta, et al.
Lung India : Official Organ of Indian Chest Society|January 3, 2022
Clinical features, demography, and predictors of outcomes of SARS-CoV-2 infection at a tertiary care hospital in India: A cohort studyArunmozhimaran Elavarasi, Hari Krishna Raju Sagiraju, Rohit Kumar Garg, et al.
The Lancet. Microbe|May 11, 2022
A controlled human infection model of Streptococcus pyogenes pharyngitis (CHIVAS-M75): an observational, dose-finding studyJoshua Osowicki, Kristy I Azzopardi, Loraine Fabri, et al.
Pageof 15

Showing results (141-150 of 146) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 146 results.
Trials|November 20, 2024
A phase 1 randomized controlled trial of a peptide-based group A streptococcal vaccine in healthy volunteersVanessa Meier-Stephenson, Michael T Hawkes, Catherine Burton, et al.
Clinical & Translational Immunology|March 18, 2021
Antibodies to neutralising epitopes synergistically block the interaction of the receptor-binding domain of SARS-CoV-2 to ACE 2Manisha Pandey, Victoria Ozberk, Sharareh Eskandari, et al.
Lung India : Official Organ of Indian Chest Society|April 30, 2022
Silent Hypoxia in Coronavirus disease-2019: Is it more dangerous? -A retrospective cohort studyPrashant Sirohiya, Arunmozhimaran Elavarasi, Hari Krishna Raju Sagiraju, et al.
Indian Journal of Community Medicine : Official Publication of Indian Association of Preventive & Social Medicine|February 6, 2023
The Effectiveness of SARS-CoV-2 Vaccination in Preventing Severe Illness and Death - Real-world Data from a Cohort of Patients Hospitalized with COVID-19Hari Krishna Raju Sagiraju, Arunmozhimaran Elavarasi, Nishkarsh Gupta, et al.
Lung India : Official Organ of Indian Chest Society|January 3, 2022
Clinical features, demography, and predictors of outcomes of SARS-CoV-2 infection at a tertiary care hospital in India: A cohort studyArunmozhimaran Elavarasi, Hari Krishna Raju Sagiraju, Rohit Kumar Garg, et al.
The Lancet. Microbe|May 11, 2022
A controlled human infection model of Streptococcus pyogenes pharyngitis (CHIVAS-M75): an observational, dose-finding studyJoshua Osowicki, Kristy I Azzopardi, Loraine Fabri, et al.
Pageof 15